Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Effectiveness and Safety of X A-DERM™ Microsurfaced Acellular Dermal Matrix for Wound Healing After MOHS Surgery [NA]
Completed trial evaluating the effectiveness and safety of X A-DERM Microsurfaced Acellular Dermal Matrix for wound healing after Mohs micro…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia [Phase 2]
Phase 2 trial evaluating quercetin for chemoprevention of squamous cell carcinoma in patients with Fanconi anemia has completed with results…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin [Phase 2]
Phase 2 clinical trial investigating COL7A1 gene therapy to reduce recurrence of squamous cell carcinoma in skin affected by recessive dystr…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers [Phase 1, Phase 2]
A Phase Ib/II clinical trial evaluating HMBD-001, an anti-HER3 antibody, in combination with cetuximab with or without docetaxel for advance…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Disposable Negative Pressure Wound Therapy Device (SNaP) to Promote Wound Healing in the Lower Limbs Following Mohs Micrographic Surgery for Non-melanoma Skin Cancer [NA]
This clinical trial update describes a disposable negative pressure wound therapy device (SNaP) being studied to promote wound healing after…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC [Phase 1]
A Phase 1 clinical trial update for TBio-4101 with pembrolizumab, with or without chemotherapy, in recurrent or metastatic head and neck squ…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating a T cell receptor–based immunotherapy for patients with metastatic non-small cell lung cancer is current…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
Clinical trial aiming to define the natural history of squamous cell carcinoma in people with Fanconi anemia and inherited bone marrow failu…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT) [NA]
Clinical trial investigating the effects of vitamin D on the immune microenvironment of non-melanoma skin cancer after photodynamic therapy;…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Rigosertib for RDEB-SCC [Phase 1, Phase 2]
Completed Phase 1/2 clinical trial evaluating rigosertib for squamous cell carcinoma associated with recessive dystrophic epidermolysis bull…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck [NA]
Update on Version 2.0 of a de-intensification protocol for transoral robotic surgery (TORS) in oropharyngeal cancer, detailing dose and neck…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP) [NA]
A clinical trial update describing the Italian Tumor Chemogenomic Profiler (IT-TCP), an integrative multi-omics and functional platform to d…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors [Phase 1]
Phase 1 trial evaluating oral ABBV-711 as a monotherapy and in combination with intravenous Budigalimab (ABBV-181) in adults with advanced s…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
This clinical trial update analyzes clinical outcomes and genomic data from American Indian patients across several cancer indications, with…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Stanford University is conducting a clinical trial evaluating novel serum markers to monitor response to anti-cancer therapy. The study is c…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Intratumoral N17350 in Advanced Solid Tumors [Phase 1, Phase 2]
Update on the investigational intratumoral therapy N17350 being studied in advanced solid tumors in Phase 1 and Phase 2 trials, sponsored by…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Investigation of Effect of Formulated Methylene Blue on Treatment of Squamous Cell Carcinoma Skin Cancer in Inoperable Patients and Not Suitable for Radiotherapy [Phase 3]
A Phase 3 clinical trial is enrolling to evaluate formulated methylene blue for treating squamous cell carcinoma of the skin in patients who…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Neo-adjuvant Treatment for Squamous Cell Carcinoma Using Direct Tumor Injection With RP1. [Phase 1, Phase 2]
Phase 1/2 trial evaluating direct tumor injections of RP1 as neoadjuvant therapy for squamous cell carcinoma; the study is active but not re…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma [NA]
The trial update indicates that the electronic skin surface brachytherapy study for cutaneous basal cell carcinoma and cutaneous squamous ce…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma [Phase 1]
Phase 1 study evaluating IRX-2 regimen with durvalumab for incurable head and neck squamous cell carcinoma has completed, including multiple…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Determining the Prevalence of Muir-Torre Syndrome in Patients With Lynch Syndrome [NA]
A not-yet-recruiting clinical study at Centre Hospitalier Universitaire de Nîmes aims to determine how prevalent Muir-Torre Syndrome is amon…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study of intratumoral MVR-T3011 given alone or with pembrolizumab in adults with advanced o…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
Expanded Access program for AVM0703 is available to eligible patients with several solid tumor and blood cancer indications, including gliob…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment [Phase 1, Phase 2]
A Phase 1/2 clinical trial is investigating the combination of fractional laser treatment with tirbanibulin ointment for basal cell carcinom…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors [Phase 1]
This update describes a Phase 1 trial of R-5780-01 in combination with PD-1 checkpoint inhibitors for solid tumors, currently recruiting.